Viewing Study NCT04599478



Ignite Creation Date: 2024-05-06 @ 3:19 PM
Last Modification Date: 2024-10-26 @ 1:47 PM
Study NCT ID: NCT04599478
Status: RECRUITING
Last Update Posted: 2023-08-31
First Post: 2020-10-21

Brief Title: Pharmacological and Behavioral Treatment After Bariatric Surgery Acute Stage 1
Sponsor: Yale University
Organization: Yale University

Study Overview

Official Title: Pharmacological and Behavioral Treatments to Treat Loss-of-Control Eating and Improve Weight Outcomes After Bariatric Surgery Acute Stage 1
Status: RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study will compare the effectiveness of behavioral and pharmacologic treatments alone and in combination for the treatment of loss-of-control eating and weight following bariatric surgery This is an acute treatment comparing behavioral weight loss alone or in combination with combination naltrexonebupropion medication
Detailed Description: Participants who provide informed consent and are determined to be eligible will then participate in the study

A total of 160 patients with obesity and regular LOC-eating following MBS will be randomly assigned double-blind in a balanced factorial 2 X 2 design to one of four 16-week interventions BWLNB BWLPlacebo NB or Placebo The randomization will be in equal proportions but stratified by surgery type

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
R01DK126637-01 NIH None httpsreporternihgovquickSearchR01DK126637-01